New hope for rare sarcoma: phase 3 drug trial now recruiting
NCT ID NCT03016819
First seen Feb 27, 2026 · Last updated Apr 28, 2026 · Updated 8 times
Summary
This study tests a drug called AL3818 (anlotinib) for people with a rare cancer called alveolar soft part sarcoma that has spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants take the drug by mouth daily, and the study tracks how well it works and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEIOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
COMPLETEDBeijing, China
-
Columbia University Medical Center
WITHDRAWNNew York, New York, 10032, United States
-
Hospital de la Santa Creu i Sant Pau
COMPLETEDBarcelona, Spain
-
Istituto Nazionale dei Tumori
COMPLETEDMilan, Italy
-
MD Anderson Cancer Center
COMPLETEDHouston, Texas, 77030, United States
-
Mayo Clinic Arizona
COMPLETEDPhoenix, Arizona, 85054, United States
-
Mayo Clinic Jacksonville
COMPLETEDJacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
COMPLETEDRochester, Minnesota, 55905, United States
-
Northwestern University
COMPLETEDChicago, Illinois, 60611, United States
-
Royal Marsden Hospital
NOT_YET_RECRUITINGLondon, SW3 6JJ, United Kingdom
Contact
Contact Email: •••••@•••••
-
Sarcoma Oncology Center
RECRUITINGSanta Monica, California, 90403, United States
Contact
Contact Email: •••••@•••••
-
Shanghai Sixth People's Hospital
COMPLETEDShanghai, China
-
Stanford Medicine Cancer Institute
COMPLETEDStanford, California, 94305, United States
-
Thomas Jefferson Hospital - Sidney Kimmel Cancer Center
COMPLETEDPhiladelphia, Pennsylvania, 19107, United States
-
UW Medicine-Seattle Cancer Care Alliance
COMPLETEDSeattle, Washington, 98109, United States
-
University Campus Bio-Medico
COMPLETEDRome, Italy
-
University of California Los Angeles
COMPLETEDLos Angeles, California, 90404, United States
-
University of Colorado Denver
COMPLETEDAurora, Colorado, 80045, United States
-
University of Miami Sylvester Comprehensive Cancer Center
COMPLETEDMiami, Florida, 33136, United States
-
University of Michigan Comprehensive Cancer Center
COMPLETEDAnn Arbor, Michigan, 48109, United States
-
University of Palermo
COMPLETEDPalermo, Italy
-
University of Pittsburgh Medical Center
COMPLETEDPittsburgh, Pennsylvania, 15219, United States
-
Vanderbilt University
COMPLETEDNashville, Tennessee, 37203, United States
-
Washington University St. Louis
COMPLETEDSt Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.